Alex Zhavoronkov
InvestorCo-founder and Head of the Advisory Board at LongeVC
About
Alex Zhavoronkov is the CEO of Insilico Medicine, a Baltimore-based company applying artificial intelligence and blockchain to drug discovery, biomarker development, and aging research. He co-founded LongeVC and heads its Advisory Board, and previously held senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research Foundation, and YLabs.AI. He holds two Bachelor's degrees from Queen's University, a Master's in Biotechnology from Johns Hopkins University, and a PhD in Physics and Mathematics from Moscow State University.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechLongevity
Colleagues at LongeVC
Artem Trotsyuk
Operating Partner - US at LongeVC
Artemy Shumskiy
Principal at LongeVC
Christine Yuan Huang
Advisory Board at LongeVC
Dr. Weigao Wang
Venture Fellow at LongeVC
Evelyne Bischof
Venture Partner at LongeVC
Evgeny Izumchenko
Venture Partner at LongeVC
Garri Zmudze
Managing Partner at LongeVC
Gege Qian
Venture Fellow (2023 Class) at LongeVC
Frequently asked questions
- Who is Alex Zhavoronkov?
- Alex Zhavoronkov is the CEO of Insilico Medicine, a Baltimore-based company applying artificial intelligence and blockchain to drug discovery, biomarker development, and aging research. He co-founded LongeVC and heads its Advisory Board, and previously held senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research Foundation, and YLabs.AI. He holds two Bachelor's degrees from Queen's University, a Master's in Biotechnology from Johns Hopkins University, and a PhD in Physics and Mathematics from Moscow State University.
- Where does Alex Zhavoronkov work?
- Alex Zhavoronkov is Co-founder and Head of the Advisory Board at LongeVC.
- What does Alex Zhavoronkov invest in?
- Alex Zhavoronkov invests in AI & Machine Learning, Biotech, Longevity.